4//SEC Filing
Sukhtian Ghiath M. 4
Accession 0000947871-22-001263
CIK 0001649989other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 5:01 PM ET
Size
7.9 KB
Accession
0000947871-22-001263
Insider Transaction Report
Form 4
Sukhtian Ghiath M.
Director10% Owner
Transactions
- Award
Common Stock
2022-12-28$0.88/sh+14,230,418$12,499,999→ 70,047,204 total(indirect: See Footnotes)
GMS Ventures & Investments
Director10% Owner
Transactions
- Award
Common Stock
2022-12-28$0.88/sh+14,230,418$12,499,999→ 70,047,204 total(indirect: See Footnotes)
Footnotes (2)
- [F1]These securities are held of record by GMS Ventures & Investments ("GMS Ventures"). Ghiath M. Sukhtian ("Ghiath Sukhtian"), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.
- [F2]By virtue of the relationships described above in Footnote 1, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001717441
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 5:01 PM ET
- Size
- 7.9 KB